These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28760882)

  • 1. Modified Vaccinia Virus Ankara Vector Induces Specific Cellular and Humoral Responses in the Female Reproductive Tract, the Main HIV Portal of Entry.
    Marlin R; Nugeyre MT; Tchitchek N; Parenti M; Hocini H; Benjelloun F; Cannou C; Dereuddre-Bosquet N; Levy Y; Barré-Sinoussi F; Scarlatti G; Le Grand R; Menu E
    J Immunol; 2017 Sep; 199(5):1923-1932. PubMed ID: 28760882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seminal Plasma Exposures Strengthen Vaccine Responses in the Female Reproductive Tract Mucosae.
    Marlin R; Nugeyre MT; Tchitchek N; Parenti M; Lefebvre C; Hocini H; Benjelloun F; Cannou C; Nozza S; Dereuddre-Bosquet N; Levy Y; Barré-Sinoussi F; Scarlatti G; Le Grand R; Menu E
    Front Immunol; 2019; 10():430. PubMed ID: 30915079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA-MVA-protein vaccination of rhesus macaques induces HIV-specific immunity in mucosal-associated lymph nodes and functional antibodies.
    Chege GK; Burgers WA; Müller TL; Gray CM; Shephard EG; Barnett SW; Ferrari G; Montefiori D; Williamson C; Williamson AL
    Vaccine; 2017 Feb; 35(6):929-937. PubMed ID: 28069361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
    Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
    Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified Vaccinia Virus Ankara Can Induce Optimal CD8
    Wong YC; Croft S; Smith SA; Lin LCW; Cukalac T; La Gruta NL; Drexler I; Tscharke DC
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31375596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal priming with replicative Tiantan vaccinia and systemic boosting with DNA vaccine raised strong mucosal and systemic HIV-specific immune responses.
    Huang X; Liu L; Ren L; Qiu C; Wan Y; Xu J
    Vaccine; 2007 Dec; 25(52):8874-84. PubMed ID: 18061316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type I Interferon Promotes Humoral Immunity in Viral Vector Vaccination.
    Zhong C; Liu F; Hajnik RJ; Yao L; Chen K; Wang M; Liang Y; Sun J; Soong L; Hou W; Hu H
    J Virol; 2021 Oct; 95(22):e0092521. PubMed ID: 34495698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine.
    Ramírez JC; Gherardi MM; Esteban M
    J Virol; 2000 Jan; 74(2):923-33. PubMed ID: 10623755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with recombinant modified vaccinia virus Ankara prevents the onset of intestinal allergy in mice.
    Bohnen C; Wangorsch A; Schülke S; Nakajima-Adachi H; Hachimura S; Burggraf M; Süzer Y; Schwantes A; Sutter G; Waibler Z; Reese G; Toda M; Scheurer S; Vieths S
    Allergy; 2013 Aug; 68(8):1021-8. PubMed ID: 23909913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with a modified vaccinia virus Ankara (MVA)-vectored HIV-1 immunogen induces modest vector-specific T cell responses in human subjects.
    Howles S; Guimarães-Walker A; Yang H; Hancock G; di Gleria K; Tarragona-Fiol T; Hayes P; Gilmour J; Bridgeman A; Hanke T; McMichael A; Dorrell L
    Vaccine; 2010 Oct; 28(45):7306-12. PubMed ID: 20816902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immediate-early expression of a recombinant antigen by modified vaccinia virus ankara breaks the immunodominance of strong vector-specific B8R antigen in acute and memory CD8 T-cell responses.
    Baur K; Brinkmann K; Schweneker M; Pätzold J; Meisinger-Henschel C; Hermann J; Steigerwald R; Chaplin P; Suter M; Hausmann J
    J Virol; 2010 Sep; 84(17):8743-52. PubMed ID: 20538860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
    Gómez CE; Abaitua F; Rodríguez D; Esteban M
    Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of modified vaccinia virus Ankara as an alternative vaccine against smallpox in chronically HIV type 1-infected individuals undergoing HAART.
    Cosma A; Nagaraj R; Staib C; Diemer C; Wopfner F; Schätzl H; Busch DH; Sutter G; Goebel FD; Erfle V
    AIDS Res Hum Retroviruses; 2007 Jun; 23(6):782-93. PubMed ID: 17604541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mucosal immune system in the human female reproductive tract: potential insights into the heterosexual transmission of HIV.
    Yeaman GR; White HD; Howell A; Prabhala R; Wira CR
    AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S57-62. PubMed ID: 9581885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient Induction of Cytotoxic T Cells by Viral Vector Vaccination Requires STING-Dependent DC Functions.
    Barnowski C; Ciupka G; Tao R; Jin L; Busch DH; Tao S; Drexler I
    Front Immunol; 2020; 11():1458. PubMed ID: 32765505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel naturally occurring tandem promoter in modified vaccinia virus ankara drives very early gene expression and potent immune responses.
    Wennier ST; Brinkmann K; Steinhäußer C; Mayländer N; Mnich C; Wielert U; Dirmeier U; Hausmann J; Chaplin P; Steigerwald R
    PLoS One; 2013; 8(8):e73511. PubMed ID: 23951355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Chimeric HIV-1 gp120 Fused with Vaccinia Virus 14K (A27) Protein as an HIV Immunogen.
    Vijayan A; García-Arriaza J; Raman SC; Conesa JJ; Chichón FJ; Santiago C; Sorzano CÓ; Carrascosa JL; Esteban M
    PLoS One; 2015; 10(7):e0133595. PubMed ID: 26208356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cells from a high proportion of apparently naive cattle can be activated by modified vaccinia virus Ankara (MVA).
    Sandbulte MR; Platt R; Roth JA
    Viral Immunol; 2004; 17(1):39-49. PubMed ID: 15018661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B5-deficient vaccinia virus as a vaccine vector for the expression of a foreign antigen in vaccinia immune animals.
    Viner KM; Girgis N; Kwak H; Isaacs SN
    Virology; 2007 May; 361(2):356-63. PubMed ID: 17188733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early evaluation of the safety, reactogenicity, and immune response after a single dose of modified vaccinia Ankara-Bavaria Nordic vaccine against mpox in children: a national outbreak response.
    Ladhani SN; Dowell AC; Jones S; Hicks B; Rowe C; Begum J; Wailblinger D; Wright J; Owens S; Pickering A; Shilltoe B; McMaster P; Whittaker E; Zuo J; Powell A; Amirthalingam G; Mandal S; Lopez-Bernal J; Ramsay ME; Kissane N; Bell M; Watson H; Ho D; Hallis B; Otter A; Moss P; Cohen J
    Lancet Infect Dis; 2023 Sep; 23(9):1042-1050. PubMed ID: 37336224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.